Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-01-28EMA Authorised: Saphnelo (anifrolumab) — AstraZeneca AB
The European Medicines Agency authorised Saphnelo (anifrolumab) for systemic lupus erythematosus, expanding EU treatment options. The market…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy [EARLY_Phase 1]
An early-phase 1 clinical trial of IMPT-514 in systemic lupus erythematosus, ANCA-associated vasculitis, and idiopathic inflammatory myopath…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE [Phase 1]
Phase 1 trial update evaluating safety, tolerability, pharmacokinetics, immunogenicity and preliminary efficacy of HC022 injection in system…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease [Phase 4]
Phase 4 clinical trial comparing telitacicept to cyclophosphamide for lupus-related interstitial lung disease, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: BENLYSTA® Special Drug Use Investigation
This entry notes the completion of GlaxoSmithKline's Special Drug Use Investigation for BENLYSTA (belimumab) in systemic lupus erythematosus…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis [Phase 1]
Phase 1 study evaluating UB-VV410 in adults with active refractory systemic lupus erythematosus or lupus nephritis; recruitment is currently…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Research Accelerated by You Lupus Registry
This clinical trial registry entry describes the Lupus Registry study sponsored by the Lupus Foundation of America, which is currently recru…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus [Phase 1, Phase 2]
CRC01 is being evaluated in a Phase 1/2 clinical trial for severe refractory systemic lupus erythematosus, including lupus nephritis, with t…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 trial evaluating autologous CD19/BCMA dual-target CAR-T therapy for relapsed/refractory autoimmune diseases; currently recruiting at…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis
A completed study by GlaxoSmithKline examining demographic, pharmacologic, biomarker, clinical features, and quality of life in participants…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: KN5501 Cell Injection for Refractory SLE(CLEAR) [Phase 1]
Phase 1 trial update for KN5501 cell injection in refractory systemic lupus erythematosus (SLE) by Ruitherapeutics Co., Ltd. The study is cu…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating QT-019C, a CD19 and BCMA-targeted CAR T-cell therapy, for relapse/refractory autoimmune diseases; recrui…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: It is an Observational Study That Compare Prognosis of Typical and Atypical Systemic Lupus Erythematosus Presentation
An observational study comparing prognosis between typical and atypical presentations of systemic lupus erythematosus. The study is not yet …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Exploring and Measuring the Impact of Steroids in Children and Young People
A recruiting clinical trial investigating how steroids affect health outcomes in children and young people with rheumatic diseases, includin…
-
CLINICAL_TRIALS other · 2026-01-20Clinical Trial Update: Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric Setting [NA]
A clinical trial update describes a pediatric study evaluating hypnotherapy to manage needle-related pain and anxiety during procedures; the…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: HLA Antibodies in Systemic Lupus Erythematosus
A clinical trial is currently recruiting to study HLA antibodies in patients with Systemic Lupus Erythematosus at Centre Hospitalier Univers…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]
Early-phase clinical study evaluating universal CD19/CD20 CAR-T cell therapy for safety and potential efficacy in moderate to severe refract…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases [EARLY_Phase 1]
An early Phase 1 clinical trial evaluating the safety and efficacy of a targeted BCMA in vivo lentiviral vector injection for recurrent or r…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) [Phase 1]
Phase 1 Breakfree-1 trial evaluating CC-97540, a CD-19-targeted Nex-T CAR T cell therapy, for severe, refractory autoimmune diseases; the st…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE [Phase 1]
Phase 1 clinical trial evaluating Ultra-Fast CD19 CAR-T cell therapy for refractory systemic lupus erythematosus is currently recruiting. Th…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1) [Phase 3]
A Phase 3 study (REMESLE-1) evaluating telitacicept for moderately to severely active systemic lupus erythematosus has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: BCMA-CD19 cCAR T for the Treatment of Refractory Lupus [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating BCMA-CD19 cCAR T therapy for refractory systemic lupus erythematosus and lupus nephritis, sponsored by…
-
CLINICAL_TRIALS withdrawal · 2026-01-09Clinical Trial Update: A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) [Phase 3]
The REMESLE-2 Phase 3 trial of telitacicept for moderately to severely active systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases [Phase 1]
Century Therapeutics’ CNTY-101 is being evaluated in a Phase 1 study for refractory B cell–mediated autoimmune diseases, with the trial curr…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Creating Health Course Study for People With Rheumatological Conditions [NA]
A new health course study for people with rheumatological conditions is currently recruiting, spanning rheumatoid arthritis, Sjögren's syndr…